In Brief

An interim CRO restructuring mandate is the right answer for a loss-making Czech subsidiary. Liquidity, in that situation, runs to weeks, not months. Banks and suppliers have already moved to defensive terms. The statutory director carries personal exposure under the Czech Insolvency Act for delaying an insolvency filing. An Interim Managing Director mandate fits instead when the plant is fundamentally viable. Cash covers twelve to sixteen weeks of operations. The loss traces to operational execution, not balance-sheet distress. The two mandates carry different statutory authority and a different definition of success. Appointing the wrong one compounds the problem it was meant to solve.

Evaluating a Turnaround or Closure Decision When a Foreign Subsidiary Incurs Losses

Boards rarely decide, in a single meeting, that a foreign plant has become an existential risk. The pattern is usually slower. A Central European manufacturing subsidiary reports another quarter of losses. The board discusses it. That discussion tends to focus on people, not structure. Directors consider replacing the expatriate plant director. Or they ask the regional commercial director to oversee the site, alongside their existing job.

That instinct is understandable. Owners have often invested tens of millions of euros in land, machinery and tooling. They naturally want to believe better local leadership can fix the plant. They resist accepting that the entity itself may be at risk. The difficulty is that this instinct answers an operational question. Increasingly, though, the real question is a statutory one. It needs an interim CRO restructuring mandate to answer it properly, not a management reshuffle.

Boards lose time when they conflate operational inefficiency with structural insolvency. Scrap rates, machine downtime and late deliveries describe an operational problem. Depleted liquidity, covenant breaches, negative equity and director liability describe a different one. A brief that does not separate the two usually produces an ambiguous appointment. Ambiguous appointments are where executive turnover and continued value loss tend to start.

Understanding the Czech Insolvency Act and Personal Liability for the Statutory Jednatel

In the Czech Republic, this choice is not only an organisational preference. Czech corporate and insolvency law shapes the decision directly. That law applies to the local entity, wherever its owner sits.

The Czech Insolvency Act (Act No. 182/2006 Coll.) sets three duties. Boards should understand each before making this appointment:

• The duty to file. Section 98 requires the statutory executive (jednatel) to file an insolvency petition without undue delay. The clock starts once the company becomes aware of its own insolvency, or of impending insolvency (hrozící úpadek). It also starts once the company reasonably should have known.
• Personal liability. Section 99 makes an executive who breaches that duty personally liable to creditors. Courts calculate the damage as the difference between the creditor’s established claim and the amount the creditor actually received.
• Duty of due managerial care. Czech law expects directors to act with the diligence and loyalty their office requires (péče řádného hospodáře). This duty carries real consequences during financial distress. A director who keeps the company trading without a credible recovery plan can face a personal claim.

Why Parent Headquarters Misjudges Balance-Sheet Risk and Solvency in Foreign Subsidiaries

A parent board based in Germany, Austria or Switzerland can misread this framework easily. Group finance functions often treat the Czech entity as an internal cost centre. They assume the parent’s balance sheet and treasury function protect the local entity from legal consequence.

Czech law assesses the subsidiary on its own footing, not the parent’s. Two legal tests decide this. The entity may carry too much debt relative to its assets (over-indebted, předlužení). Or it may be unable to meet matured obligations (platební neschopnost). Either test bars the statutory body from lawfully continuing to trade without a credible recovery plan. That holds true whatever informal support the parent believes it is providing.

An interim CRO restructuring mandate exists precisely to close this gap. A capable operator cannot close it simply by working harder. McKinsey’s analysis of when companies appoint a Chief Restructuring Officer names two reasons boards look outside the existing management team. The first is independent credibility with lenders and directors. The second is the ability to hold competing stakeholder interests together under sustained pressure. An Interim Managing Director, however capable operationally, does not carry that specific statutory and stakeholder role.

Diagnostic Matrix: Identifying When You Need an Interim CRO or an Interim Managing Director

The diagnostic below exists to answer one question. Does this subsidiary need an interim CRO restructuring mandate, or an Interim Managing Director? Five dimensions separate the two situations in practice.

A subsidiary can sit closer to one column on most dimensions and still need a closer look on the others. Treat the diagnostic as a starting point for the board’s own assessment, not a substitute for it.

Key Strategic Trade-Offs Between Chief Restructuring Officer and Managing Director Roles

One trade-off sits underneath this table. A CRO mandate buys statutory protection and centralised crisis authority. It costs the plant some of its existing commercial relationships and day-to-day operational momentum. An MD mandate protects those relationships and that momentum. It does nothing to reduce a director’s personal exposure if the diagnostic turns out to be wrong.

Defining Mandate Scope and Objectives Before Appointing Executive Leadership

Once the board works through the diagnostic, the mandate itself needs the same precision. Neither an interim CRO restructuring mandate nor an Interim MD mandate should be written as a hybrid. A mandate that reads as part-time turnaround leadership and part-time commercial growth rarely succeeds. Both halves compete for the same hours. The executive ends up accountable for outcomes without the authority to control either one.

Structuring an Effective Interim CRO Restructuring Mandate for Financial Turnarounds

Where the diagnostic points to an existential threat, the CRO needs approval authority over outbound payments from day one. A 13-week direct cash flow forecast supports that authority; the CRO reconciles it against actual bank transactions rather than projections.

The CRO’s mandate sits outside the plant’s existing local relationships. That distance lets the executive take decisions those relationships would otherwise slow. The CRO can renegotiate or exit unviable supply contracts. They can also execute workforce reductions where the diagnostic shows they are unavoidable.

The CRO becomes the single point of contact with banks, tax authorities and restructuring advisors. This removes the parent board from direct negotiation. The CRO reports to the Group CEO or Supervisory Board. That report gives an unfiltered view of whether the business can reach sustainable viability. This differs from an interim CEO restructuring mandate, where the executive holds enterprise-wide authority rather than a single plant-level appointment.

Structuring an Interim Managing Director Manufacturing Mandate for Operational Recovery

Where the diagnostic points to an operational recovery, the mandate keeps the executive on site for most of the assignment. Production planning and shop-floor supervision come first. Part of the role is renegotiating contracts the business priced under assumptions it can no longer support. The Interim MD works closely with group sales on this, not around them.

The remainder is rebuilding a stable operational hierarchy. That means reducing avoidable technician turnover. It also means giving the plant a management structure that holds once the Interim MD leaves.

Managing Cross-Border Governance: Aligning Group Strategy with Local Statutory Duties

A DACH-based parent board and a Czech statutory body are not competing for control of this decision. They face different consequences from the same set of facts. The parent board answers to its own shareholders and lenders for the capital it has already committed. It also answers for the group’s reputation with customers who depend on the plant. The Czech statutory body carries personal legal exposure the moment insolvency becomes apparent. That holds regardless of what the parent board decides next.

This is precisely the kind of gap CE Interim exists to close. CE Interim does not choose a side between headquarters and the local entity. It establishes a single, verified fact base. It places an executive with the correct statutory authority in position to act on it. That executive stays accountable to the parent board for the outcome. Where the mandate requires it, the board also formally registers the executive to carry the Czech statutory obligations personally.

Escalation runs in both directions. The parent board needs to know within days, not months. Is this an operational recovery, or a solvency event? The local statutory body needs the authority and the mandate clarity to act the moment the board knows the answer. An interim CRO restructuring mandate exists to give both sides that clarity at the same time, not one before the other.

Case Study: Interim Restructuring Leadership at a Czech Precision Engineering Subsidiary

A German precision automotive component group owned a 400-employee manufacturing subsidiary near Liberec, Czech Republic. Three years of unprofitability had produced an operating loss of EUR 4.8 million on EUR 32 million of turnover. The Munich parent board disagreed sharply. The Group COO argued for a veteran plant manager. The Group CFO warned that local banks were close to withdrawing working capital facilities.

CE Interim ran a rapid operational and financial triage. CE Interim provided a proven, mandate-matched executive for the Liberec site. The executive was ready to start within 72 hours of the completed mandate brief.

The diagnostic found the subsidiary was roughly three weeks from cash depletion. The subsidiary had already breached its bank covenants. Suppliers had moved to cash-on-delivery terms. The statutory accounts showed negative equity. An operational plant manager, however capable, would have faced creditor calls and legal notices. The role never anticipated that kind of exposure.

The Four-Stage Restructuring Plan Executed by the Chief Restructuring Officer

The board chose an interim CRO restructuring mandate over a straightforward plant manager appointment. It appointed the executive as Chief Restructuring Officer and formally registered the appointment as jednatel. The CRO ran a four-stage recovery plan:

1. Creditor standstill. The CRO secured a 90-day standstill agreement with the banking syndicate, built on a transparent, validated 13-week cash preservation model.
2. Contract rationalisation. The CRO issued formal price renegotiation demands to OEM customers, and scheduled unprofitable product lines for orderly phase-out.
3. Operational rightsizing. The CRO restructured production from four partially loaded shifts to two fully utilised shifts. This reduced direct headcount by 28%, in compliance with Czech labour regulations.
4. Transition to operational leadership. By day 100, operating cash flow had turned positive and vendor terms had normalised.

The CRO had removed the insolvency risk and reset the cost base. The CRO then handed operational leadership to a permanent Czech Managing Director, recruited to lead the business forward.

Frequently Asked Questions: Interim CRO and Interim CEO Restructuring Mandates

Can a Chief Restructuring Officer and an Interim Managing Director work at the same time?

Yes, in large, complex sites, they can run in parallel. The CRO manages external liquidity while the Interim MD handles internal production. However, in mid-sized subsidiaries, a single executive prevents divided leadership. CE Interim structures the exact leadership footprint your plant needs, deploying either a dual-force or a unified executive to ensure rapid, decisive action.

Why not simply recruit a permanent Managing Director to fix the plant?

Permanent recruitment takes four to six months, time a distressed entity’s cash position rarely allows. Furthermore, restructuring decisions consume significant political capital that a new permanent leader needs to preserve. CE Interim bridges this critical gap by deploying an objective interim executive to execute the tough, unpopular decisions, leaving your permanent hire with a clean slate for the recovery phase.

What personal legal exposure does a jednatel face at a distressed Czech company?

Under Sections 98 and 99 of the Czech Insolvency Act, a statutory director (jednatel) faces severe personal liability for delaying an insolvency filing. This risk triggers the moment distress becomes apparent. CE Interim mitigates this legal exposure by rapidly assessing the true financial state and assuming the statutory authority needed to navigate Czech insolvency laws safely.

How long does an interim CRO restructuring mandate typically last?

An interim CRO mandate usually runs four to eight months to stabilize the balance sheet for a final turnaround or closure decision, while an Interim MD mandate runs six to nine months. CE Interim drives these targeted timelines, ensuring the operation is either safely restructured or completely stabilized before executing a structured handover to permanent leadership.

Who should decide whether the plant needs a CRO or an MD?

The board makes the final decision, but the diagnostic must be run independently, as internal reporting is often highly unreliable during a crisis. CE Interim clarifies this choice by conducting an objective, unvarnished assessment of the plant’s true condition, empowering the board to confidently appoint the exact leadership profile required.

What happens if the board delays making this decision?

Delaying allows liquidity and stakeholder conflicts to deteriorate rapidly; a subsidiary with healthy cash today can require a drastic CRO intervention within a single quarter. CE Interim halts this downward spiral by executing an early, independent diagnostic, preserving your strategic options before the crisis dictates the outcome for you.

Next Steps: Selecting the Right Interim Executive for Your Czech Manufacturing Plant

Choosing between a Chief Restructuring Officer and an Interim Managing Director is a consequential decision. It is one of the most significant mandate calls a board makes for a distressed foreign subsidiary. It is also a statutory decision with personal consequences for whoever holds the jednatel role. Getting the diagnostic right, before the appointment, protects enterprise value and the individuals accountable for it. The answer might be an interim CRO restructuring mandate, or it might be an Interim Managing Director appointment. Either way, the diagnostic above should drive the decision, not instinct.

Related Reading:

• Reestructuración, saneamiento o cierre: elegir el futuro adecuado para una planta checa
• Cuando las cuentas no cuadran: investigar una planta checa sin provocar el caos
• Cuando el cierre de una planta polaca afecta al calendario de reestructuración checo: por qué resulta imposible tomar decisiones paralelas

Is your board assessing the leadership requirements for a loss-making or distressed Czech subsidiary? A Socio interino de CE can help define the mandate the situation actually requires.